These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
144 related items for PubMed ID: 6573527
1. Cutaneous melanoma in relation to exogenous hormones and reproductive factors. Holly EA, Weiss NS, Liff JM. J Natl Cancer Inst; 1983 May; 70(5):827-31. PubMed ID: 6573527 [Abstract] [Full Text] [Related]
4. Case-control study of borderline ovarian tumors: reproductive history and exposure to exogenous female hormones. Harlow BL, Weiss NS, Roth GJ, Chu J, Daling JR. Cancer Res; 1988 Oct 15; 48(20):5849-52. PubMed ID: 3167840 [Abstract] [Full Text] [Related]
5. Researchers can now investigate long-term effects of OCs on cancer. Rubin GL, Peterson HB. Contracept Technol Update; 1985 Jan 15; 6(1):7-12. PubMed ID: 12279918 [Abstract] [Full Text] [Related]
6. Cutaneous malignant melanoma in women: exogenous sex hormones and reproductive factors. Holman CD, Armstrong BK, Heenan PJ. Br J Cancer; 1984 Nov 15; 50(5):673-80. PubMed ID: 6498065 [Abstract] [Full Text] [Related]
9. The Danish case-control study of cutaneous malignant melanoma. III. Hormonal and reproductive factors in women. Osterlind A, Tucker MA, Stone BJ, Jensen OM. Int J Cancer; 1988 Dec 15; 42(6):821-4. PubMed ID: 3192324 [Abstract] [Full Text] [Related]
13. Reproductive and menopausal factors and risk of systemic lupus erythematosus in women. Costenbader KH, Feskanich D, Stampfer MJ, Karlson EW. Arthritis Rheum; 2007 Apr 01; 56(4):1251-62. PubMed ID: 17393454 [Abstract] [Full Text] [Related]
14. Cutaneous malignant melanoma in women. Phenotypic characteristics, sun exposure, and hormonal factors: a case-control study from Italy. Naldi L, Altieri A, Imberti GL, Giordano L, Gallus S, La Vecchia C, Oncology Study Group of the Italian Group for Epidemiologic Research in Dermatology (GISED). Ann Epidemiol; 2005 Aug 01; 15(7):545-50. PubMed ID: 16029848 [Abstract] [Full Text] [Related]
15. Incidence of endometrial cancer in relation to the use of oral contraceptives. Weiss NS, Sayvetz TA. N Engl J Med; 1980 Mar 06; 302(10):551-4. PubMed ID: 7351890 [Abstract] [Full Text] [Related]
16. Oral contraceptive use and malignant melanoma. Bain C, Hennekens CH, Speizer FE, Rosner B, Willett W, Belanger C. J Natl Cancer Inst; 1982 Apr 06; 68(4):537-9. PubMed ID: 6951070 [Abstract] [Full Text] [Related]
18. The risk of serious illness among oral contraceptive users: evidence from the RCGP's oral contraceptive study. Hannaford PC, Kay CR. Br J Gen Pract; 1998 Oct 06; 48(435):1657-62. PubMed ID: 10071398 [Abstract] [Full Text] [Related]
19. Risks of oral contraceptive use in women over 35. Stenchever MA. J Reprod Med; 1993 Dec 06; 38(12 Suppl):1030-5. PubMed ID: 8120860 [Abstract] [Full Text] [Related]
20. [Cardiovascular risks of oral contraceptives: dose-response relationship]. Kelleher CC. Contracept Fertil Sex (Paris); 1991 Apr 06; 19(4):285-8. PubMed ID: 12343220 [Abstract] [Full Text] [Related] Page: [Next] [New Search]